| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.5 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.5 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.5 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.5 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.036 | 0.5 |
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |